Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial session on understanding the Current Cancer Scenario in India. The landscape of cancer care in India is rapidly evolving, with a growing emphasis on personalized medicine. The integration of genomic testing has become increasingly important, moving beyond a one-size-fits-all approach to diagnosis and treatment. Recent advancements in technology and a better understanding of cancer biology are enabling healthcare providers to identify specific genetic mutations that drive tumor growth, leading to more targeted and effective therapies.
In a country as diverse as India, with a unique genetic makeup across its population, the importance of genomic testing is paramount. It allows for the identification of hereditary cancer syndromes, a more accurate prognosis, and the selection of therapies that are most likely to work for an individual patient. This is particularly relevant as India grapples with a rising cancer burden, where traditional treatments may not always be the most effective. Genomic testing, therefore, provides a roadmap for clinicians to navigate the complexities of cancer, offering a new level of precision and hope for better patient outcomes.
Therefore, get a deep understanding of the current cancer scenario in India and the transformative role of genomic testing and advanced diagnostics. Listen to this insightful discussion by Dr. Poonam Patil, grab the shared knowledge on the latest advancements in diagnosis and treatment, and follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US
4.
Targeted Combination Shows Promise in Metastatic Kidney Cancer
5.
Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.
1.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
2.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
3.
Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs
4.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
5.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
3.
Efficient Management of First line ALK-rearranged NSCLC - Part II
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation